Multiple medication use in older patients in post-acute transitional care: A prospective cohort study

Clinical Interventions in Aging

Volumn 9, Issue , 2014, Pages 1453-1462

  Runganga, Maureen ^a,b   Peel, Nancye M ^b   Hubbard, Ruth E ^b,c  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Functional outcomes; Older people; Polypharmacy; Post acute care

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIEMETIC AGENT; ANTIPARKINSON AGENT; ANTIULCER AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; ESTROGEN; GLIBENCLAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NEUROLEPTIC AGENT; NOOTROPIC AGENT; PROMETHAZINE; VITAMIN D; VITAMIN D DERIVATIVE;

AGED; ARTICLE; AUSTRALIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DIZZINESS; DRUG USE; DYSPNEA; FALLING; FEMALE; FRAIL ELDERLY; FUNCTIONAL ASSESSMENT; GERIATRIC ASSESSMENT; HOME CARE; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC HEART DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POLYPHARMACY; PREVALENCE; PROSPECTIVE STUDY; DRUG INTERACTION; INAPPROPRIATE PRESCRIBING; PATIENT CARE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; COMORBIDITY; CONTINUITY OF PATIENT CARE; DRUG INTERACTIONS; FEMALE; FRAIL ELDERLY; GERIATRIC ASSESSMENT; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; POLYPHARMACY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84907502000     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S64105     Document Type: Article

References (39)

1. Hubbard RE, O’Mahony MS, Woodhouse KW. Medication prescribing in frail older people. Eur J Clin Pharmacol. 2013;69(3):319–326.
2. Slabaugh SL, Maio V, Templin M, Abouzaid S. Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy. Drugs Aging. 2010; 27(12):1019–1028.
3. Haider SI, Johnell K, Thorslund M, Fastbom J. Analysis of the associa­tion between polypharmacy and socioeconomic position among elderly aged 77 years in Sweden. Clin Ther. 2008;30(2):419–427.
4. Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predic­tors of polypharmacy among older primary care patients in Germany. Fam Pract. 2007;24(1):14–19.
5. Harugeri A, Joseph J, Parthasarathi G, Ramesh M, Guido S. Potentially inappropriate medication use in elderly patients: a study of prevalence and predictors in two teaching hospitals. J Postgrad Med. 2010; 56(3):186–191.
6. Pitkala KH, Strandberg TE, Tilvis RS. Is it possible to reduce polyphar­macy in the elderly? A randomised, controlled trial. Drugs Aging. 2001; 18(2):143–149.
7. Rockwood K, Mitnitski A. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med. 2011;27(1): 17–26.
8. Singh I, Gallacher J, Davis K, Johansen A, Eeles E, Hubbard RE. Predic­tors of adverse outcomes on an acute geriatric rehabilitation ward. Age Ageing. 2012;41(2):242–246.
9. Heuberger RA, Caudell K. Polypharmacy and nutritional status in older adults: a cross-sectional study. Drugs Aging. 2011;28(4):315–323.
10. Jyrkka J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Polyp­harmacy status as an indicator of mortality in an elderly population. Drugs Aging. 2009;26(12):1039–1048.
11. Lai SW, Liao KF, Liao CC, Muo CH, Liu CS, Sung FC. Polyphar­macy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine (Baltimore). 2010;89(5):295–299.
12. Lin CF, Wang CY, Bai CH. Polypharmacy, aging and potential drug–drug interactions in outpatients in Taiwan: a retrospective computerized screening study. Drugs Aging. 2011;28(3):219–225.
13. Olivier P, Bertrand L, Tubery M, Lauque D, Montastruc JL, Lapeyre-Mestre M. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs Aging. 2009;26(6):475–482.
14. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001; 23(8):1296–1310.
15. Schubert I, Kupper-Nybelen J, Ihle P, Thurmann P. Prescribing potentially inappropriate medication (PIM) in Germany’s elderly as indicated by the PRISCUS list. An analysis based on regional claims data. Pharmacoepidemiol Drug Saf. 2013;22(7):719–727.
16. Department of Health and Ageing. Transition Care Program Guidelines. Canberra, ACT: Australian Government; 2011. Available from http://www.health.gov.au/internet/main/publishing.nsf/content/ageing-transition-guidelines.htm. Accessed August 20, 2014.
17. Peel NM, Hubbard RE, Gray LC. Impact of post-acute transition care for frail older people: a prospective study. J Frailty Aging. 2013;2(3): 165–171.
18. Gray L., Berg K, Fries BE, et al. Sharing clinical information across care settings: the birth of an integrated assessment system. BMC Health Serv Res. 2009;9:71.
19. Hirdes J, Ljunggren G, Morris J, et al. Reliability of the interRAI suite of assessment instruments: a 12-country study of an integrated health information system. BMC Health Serv Res. 2008;8(1):277.
20. Lakhan P, Jones M, Wilson A, Courtney M, Hirdes J, Gray LC. A prospective cohort study of geriatric syndromes among older medi­cal patients admitted to acute care hospitals. J Am Geriatr Soc. 2011; 59(11):2001–2008.
21. Travers C, Byrne GJ, Pachana NA, Klein K, Gray L. Validation of the InterRAI Cognitive performance scale against indepen­dent clinical diagnosis and the mini-mental state examination in older hospitalized patients. J Nutr Health Aging. 2013;17(5):435–439.
22. Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epi­demiol. 2012;65(9):989–995.
23. Onder G, Liperoti R, Fialova D, et al. Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci. 2012;67(6):698–704.
24. Gnjidic D, Hilmer SN, Blyth FM, et al. High-risk prescribing and inci­dence of frailty among older community-dwelling men. Clin Pharmacol Ther. 2012;91(3):521–528.
25. American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–631.
26. Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatrics. 2008;8:24.
27. Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci. 2007;62(7):738–743.
28. Crentsil V, Ricks MO, Xue Q-L, Fried LP. A pharmacoepidemiologic study of community-dwelling, disabled older women: factors associ­ated with medication use. Am J Geriatr Pharmacother. 2010;8(3): 215–224.
29. Frankfort SV, Tulner LR, van Campen JP, Koks CH, Beijnen JH. Evaluation of pharmacotherapy in geriatric patients after performing complete geriatric assessment at a diagnostic day clinic. Clin Drug Investig. 2006;26(3):169–174.
30. Hosia-Randell HM, Muurinen SM, Pitkala KH. Exposure to potentially inappropriate drugs and drug–drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging. 2008;25(8):683–692.
31. Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Safety. 2007;30(10):911–918.
32. Jyrkka J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging. 2009;26(6):493–503.
33. Boyle N, Naganathan V, Cumming RG. Medication and falls: risk and optimization. Clin Geriatr Med. 2010;26(4):583–605.
34. American Geriatrics Society Workgroup on Vitamin D Supplementation for Older Adults. Recommendations abstracted from the American Geri­atrics Society Consensus Statement on Vitamin D for Prevention of Falls and Their Consequences. J Am Geriatr Soc. 2014;62(1):147–152.
35. Bischoff-Ferrari HA, Staehelin HB. Importance of vitamin D and calcium at older age. Int J Vitam Nutr Res. 2008;78(6):286–292.
36. Lampela P, Hartikainen S, Lavikainen P, Sulkava R, Huupponen R. Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a population-based inter­vention study. Drugs Aging. 2010;27(6):507–521.
37. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging. 2003; 20(11):817–832.
38. Vinks TH, Egberts TC, de Lange TM, de Koning FH. Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial. Drugs Aging. 2009;26(2):123–133.
39. Sergi G, De Rui M, Sarti S, Manzato E. Polypharmacy in the elderly: can comprehensive geriatric assessment reduce inappropriate medica­tion use? Drugs Aging. 2011;28(7):509–518.